| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Financial Officer | SVP, Alks Inc; CFO Alks
2 companies
Frates James M serves as a Chief Financial Officer at AMLX and has filed Form 4s across 2 companies. Across recent SEC filings that breaks down to 1 buy and 26 sells. Those positions are worth an estimated $8.8M at current prices.
Historically, Frates James M's trades have earned a strong insider score of 83/100 across 9 rated trades. Over a 12-month horizon, 85.7% of those trades were profitable, with an average 12-month return of +56.7%.
The biggest single holding is AMLX (~$7.8M) as Chief Financial Officer. The recent filings there lean toward selling, a net 79,222 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 10, 2026 | AMLX Amylyx Pharmaceuticals, Inc. | Chief Financial Officer | Sell | 10,810 | $32.36 | $349,820.67 | -4.4% | - | - | |
| Mar 2, 2026 | AMLX Amylyx Pharmaceuticals, Inc. | Chief Financial Officer | Sell | 7,909 | $14.52 | $114,851.33 | -4.6% | -8.0% | - | |
| Feb 2, 2026 | AMLX Amylyx Pharmaceuticals, Inc. | Chief Financial Officer | Sell | 3,557 | $14.65 | $52,096.89 | -2.0% | +12.2% | - | |
| Jan 6, 2026 | AMLX Amylyx Pharmaceuticals, Inc. | Chief Financial Officer | Sell | 3,326 | $11.11 | $36,953.86 | -1.8% | +39.0% | - | |
| Sep 30, 2025 | AMLX Amylyx Pharmaceuticals, Inc. | Chief Financial Officer | Sell | 10,558 | $14.65 | $154,650.42 | -3.6% | -10.3% | +114.1% | |
| Mar 31, 2025 | AMLX Amylyx Pharmaceuticals, Inc. | Chief Financial Officer | Sell | 10,896 | $3.47 | $37,805.85 | -3.6% | +81.1% | +292.7% | |
| Sep 12, 2024 | AMLX Amylyx Pharmaceuticals, Inc. | Chief Financial Officer | Buy | 40,000 | $2.53 | $101,368.00 | +20.7% | +75.5% | +367.9% | |
| Mar 5, 2024 | AMLX Amylyx Pharmaceuticals, Inc. | Chief Financial Officer | Sell | 1,792 | $18.73 | $33,560.40 | -1.3% | -91.0% | -82.2% | |
| Jan 9, 2024 | AMLX Amylyx Pharmaceuticals, Inc. | Chief Financial Officer | Sell | 2,716 | $16.33 | $44,347.12 | -2.4% | -83.6% | -77.0% | |
| May 16, 2023 | AMLX Amylyx Pharmaceuticals, Inc. | Chief Financial Officer | Sale+OE | 32,500 | $26.94 | $875,451.20 | -36.9% | -22.8% | -93.3% |